🔎 Trials Near Me

Home › NCT05233150

Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)

RecruitingHealthy volunteers welcome

Child-Adult Relationship Enhancement in Primary Care: Supporting Parents and Children

Who can join

18 Months – 99 Years · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Caregiver is age 18 years or older
* Caregiver is English or Spanish Speaking
* Caregiver is legal guardian of child subject
* Caregiver provides informed consent
* Caregiver is available to attend scheduled times of PriCARE/CARIÑO groups
* Caregiver has cellular phone with text messaging capacity
* Caregiver has appropriate technological tools and access to participate in virtual intervention
* Child is between 18 months and 6 years old
* Child receives care at participating primary care center
* Child has Medicaid/Children's Health Insurance Program (CHIP)/no insurance
* Child lives in North Carolina or Philadelphia

Exclusion Criteria:

* Caregiver or another caregiver in the household has previously participated in PriCARE/CARIÑO
* Child has a cognitive functioning below 2-year-old level, as determined by the screening questions and/or the referring clinician
* Child has a diagnosis of autism
* Child is receiving individual behavioral health treatment or medication for a behavioral health problem

About the study

The purpose of this study is evaluate the effectiveness of PriCARE/CARIÑO to reduce child maltreatment, improve parent-child interactions, and reduce harsh/neglectful parenting, parent stress, and child behaviors.

What is being tested

Sponsor: University of North Carolina, Chapel Hill · Participants: 1,932 · Started: May 18, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT05233150

Locations in the U.S.

North CarolinaUniversity of North Carolina Chapel Hill, Chapel Hill
PennsylvaniaChildren's Hospital of Philadelphia, Philadelphia (Not yet recruiting)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.